MMedication Read More Semaglutide mkt settles into steady growth six months after patent expiry | Industry NewsOctober 13, 2026 Six months after semaglutide lost patent protection in India, generic brands account for about 74 per cent of…
MMedication Read More Generic Ozempic, Mounjaro and GLP-1 market in India: why tirzepatide still leadsSeptember 11, 2026 When cheaper generic versions of semaglutide – originally developed by Danish drugmaker Novo Nordisk and runaway success under…
MMedication Read More Generic semaglutide market shows signs of excess inventory bulge | Industry NewsJune 12, 2026 Pharmarack data indicates elevated stock levels across several recently launched brands amid slower-than-expected liquidation in the trade…